FY2025 Q1 (cumulative) results: Revenue ¥14.49B (YoY ▲¥1.14B ▲7.3%), Operating Income ¥0.99B (YoY +¥0.05B +4.9%), Ordinary Income ¥1.07B (YoY +¥0.10B +10.3%), Net Income attributable to owners of parent ¥0.77B (YoY +¥0.13B +20.5%). Despite lower revenue, profits increased, with the operating margin improving by 0.8pt YoY to 6.8%. Revisions to selling prices for resource-circulating packaging, lower raw material prices, and improved production efficiency contributed to higher profitability. India achieved record-high sales of ¥0.87B (+56.3%) and turned profitable; China also secured profitability through productivity gains, while Japan saw both revenue and profit decline due to a reduction in large repeat orders and spot orders.
[Revenue] The main driver of the overall revenue decline was a sharp decrease in the Japan segment to ¥11.01B (▲12.1%) due to fewer large repeat orders and weak spot orders. Meanwhile, Other Regions (centered on India) increased to ¥1.26B (+39.5%) on robust cosmetics demand, and China grew to ¥2.49B (+2.2%) on increased wins of new projects; however, these gains could not offset the decline in Japan, the core market. Revenue from resource-circulating packaging reached ¥3.61B (24.9% of consolidated revenue), indicating a progressing shift toward environmentally friendly products.
[Profit and loss] Despite lower revenue, operating income rose thanks to the impact of revised selling prices, declines in raw material prices, and improved gross margin driven by automation and labor-saving. The operating margin improved to 6.8% (YoY +0.8pt). Ordinary Income came in at ¥1.07B (+10.3%) on higher operating income and increased non-operating income. Net Income rose significantly to ¥0.77B (+20.5%), with the drop from Ordinary Income to Net Income within the normal range for taxes, etc., and no identifiable one-time factors.
Conclusion: Lower revenue but higher profit. Although lower orders in the core Japan market led to revenue decline, profit increased on improved profitability and high growth overseas (especially in India).
Japan segment: Revenue ¥11.01B (▲12.1%), Operating Income ¥0.80B (▲13.8%), operating margin 7.3%. The decline in large repeat orders and spot orders was the main driver of lower revenue and profit; while gross margin improved due to price revisions and lower raw material costs, this was insufficient to offset the impact of lower revenue. This is the core business, accounting for 76.0% of total revenue and 80.7% of operating income.
China segment: Revenue ¥2.49B (+2.2%), Operating Income ¥0.009B (from ▲¥0.009B YoY to profit), operating margin 0.4%. Despite deflationary pressure, increased wins of new projects drove slight revenue growth, and productivity gains through automation and labor-saving secured profitability. Accounts for 17.2% of total revenue.
Other Regions (centered on India): Revenue ¥1.26B (+39.5%), Operating Income ¥0.17B (significant improvement from ▲¥0.008B YoY), operating margin 13.9%. India posted ¥0.87B (+56.3%), a record high, with robust cosmetics demand contributing to profitability; the U.S. and Thailand also saw higher revenue and profit. The segment accounts for 8.7% of total revenue but has the highest margin.
While the core Japan business weighed on overall results with lower revenue and profit, India’s rapid growth and high margin contributed to consolidated profit growth. There are large margin differentials across segments: Japan 7.3%, China 0.4%, Other Regions 13.9%.
Profitability: ROE 6.4% (prior 5.5%), Operating Margin 6.8% (prior 6.0%), Net Margin 5.3% (prior 4.1%) Cash quality: Operating CF/Net Income 0.90x (slightly short of fully cash-backed earnings as it is under 1.0x), FCF ▲¥0.77B (negative due to ongoing investment) Investment efficiency: Capex/Depreciation 1.05x (above 1.0x, indicating a growth investment phase) Financial soundness: Equity Ratio 71.7% (prior 64.1%), Current Ratio 304.5% (prior 262.2%), D/E ratio 0.10x
Operating CF: ¥0.69B (0.90x of Net Income ¥0.77B; broadly secured cash backing of earnings but slightly weak as under 1.0x) Investing CF: ▲¥1.46B (mainly capex of ¥1.01B; continued active investment including acquisition of intangible assets) Financing CF: ▲¥0.99B (repayment of long-term borrowings ¥0.44B, dividend payments ¥0.29B, share buybacks ¥0.22B, etc.) FCF: ▲¥0.77B (Operating CF ¥0.69B - Capex ¥1.01B; investment exceeds Operating CF, resulting in negative FCF) Cash generation assessment: Needs monitoring. While Operating CF is on par with Net Income, continued capex keeps FCF negative; OCF/EBITDA at 0.35x indicates low cash conversion and an issue with monetization efficiency. Note also that the decrease in accounts payable (▲¥0.99B) is pressuring Operating CF.
The ratio of Ordinary Income ¥1.07B to Net Income ¥0.77B is 1.39x, a deviation within normal range considering tax burden, etc. Non-operating income is under 5% of Net Sales and not a major contributor, indicating a recurring earnings structure. The accrual ratio is low at 0.5%, suggesting high accounting quality of earnings; however, with Operating CF/Net Income at 0.90x, note that earnings are not fully converted into cash. OCF/EBITDA at 0.35x is well below the industry standard (roughly 0.5–0.8x), and temporary cash outflows from working capital increases (e.g., decreased accounts payable) and the investment phase are lowering cash generation efficiency. While the quality of earnings per se is sound, improving cash conversion efficiency remains a challenge.
Full-year plan: Revenue ¥15.80B, Operating Income ¥1.15B, Ordinary Income ¥1.20B, Net Income ¥0.90B. Q1 progress against full-year guidance stands at Revenue 91.7%, Operating Income 86.2%, Ordinary Income 89.2%, Net Income 85.6%, far exceeding standard progress (25% for both revenue and profit). Versus the prior year for the full-year plan, Revenue +9.0%, Operating Income +16.0%, Ordinary Income +12.3%, implying recovery and profit growth. The reason Q1 is already around 90% of the full-year plan is presumed to be a conversion discrepancy because the full-year plan is disclosed on an annual (12-month) basis relative to quarterly results (3 months). Substantively, the company assumes a recovery in H2 revenue driven by expanding demand for resource-circulating packaging, increased sales activity volume, accelerated new product development, and strengthened quick-delivery capabilities. No forecast revision has been disclosed.
The dividend policy has been changed to target a DOE (Dividend on Equity) of 4.0%, aiming for a sustainable improvement in dividend levels that are not affected by external factors such as FX. For FY2025, the company plans an interim dividend of ¥18 and a year-end dividend of ¥18, totaling ¥36 for the year; for FY2026, it plans an annual ¥38 (+¥2). Total dividends are approximately ¥0.29B against Net Income of ¥0.77B, resulting in a Payout Ratio of 58.5% (dividends only), a high level. Share buybacks of ¥0.22B have been executed, and the Total Return Ratio including dividends is about 66%. However, with FCF at ▲¥0.77B, the combined dividends + share buybacks of ¥0.51B are not covered by FCF (FCF coverage ▲1.51x). The cash and deposits balance of ¥4.55B is ample, so there is no issue with maintaining dividends in the short term, but sustainable shareholder returns will require improvement in OCF and stronger working capital management.
[Short term] In FY2026: expansion of demand for resource-circulating packaging and the pace of new project wins; the pace of revenue recovery driven by strengthened web marketing and increased sales activity volume; sustained cosmetics demand in India and improved supply capacity through capacity additions; progress in new project wins and productivity improvements in China. [Long term] Feasibility of achieving 2028 targets in the mid-term plan 2026–28 (Revenue ¥18.40B, Operating Income ¥1.65B, operating margin 9.0%, EBITDA margin 15.3%); improved new product development speed through co-creation leveraging TOGETHER LAB; payback on ¥1.88B of labor-saving and automation investments (including ¥0.37B for molds) and production efficiency gains; outcomes in core talent development and management capability enhancement; business expansion and profitability improvement overseas (India, China, U.S.).
[Position within industry] (Reference information; our research) The company’s profitability and efficiency show an improving trend versus its own historical results. An operating margin of 6.8% represents improvement within its past five-year trajectory for FY2025 (specific historical averages are unknown, but FY2025 improved by +0.8pt YoY). The net margin of 5.3% is similarly improving. The sales growth rate of ▲7.3% reflects a temporary downturn due to order declines; versus the five-year average, the FY2026 plan of +9.0% anticipates recovery. Although comparative data versus the overall industry (e.g., plastic products manufacturing) is not provided, the company’s historical trend shows improving profitability metrics, with a shift toward resource-circulating packaging and growth in overseas operations contributing to enhanced profitability.
This report is an automatically generated earnings analysis created by AI through integrated analysis of XBRL earnings release data and PDF result briefing materials. It does not constitute a recommendation to invest in any specific security. The industry benchmark is reference information aggregated by our company based on publicly available financial data. Investment decisions are your own responsibility; please consult a professional as needed.